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The aim of this study was to investigate whether transcranial Direct Current Stimulation (tDCS) could improve
verbal memory functions in healthy old and younger participants. We hypothesized that active tDCS led to
significantly improved memory function, compared to placebo tDCS. Forty healthy participants (20 old and 20
younger participants) were included in the study. We applied a novel stimulation protocol, where six sessions of
anodal tDCS were administrated during two consecutive days. Each tDCS session lasted 30 min. The current
intensity was 2mA and the stimulation area was the left temporal lobe at T3 in the 10–20 EEG system. Immediate
recall, delayed recall and recognition memory were assessed with California Verbal Learning Test II (CVLT-II) and
executive functions were assessed with the Trail Making Test (TMT) before the first tDCS session and after the last
tDCS session. Half of the participants received placebo tDCS, whereas the other half received active tDCS. We did
not reveal any significant differences between active and placebo tDCS in memory functions. However, there was
a significant difference between active and placebo tDCS in executive function measured by the Trail Making Test
(TMT). This experimental study failed to reveal significant differences between active and placebo accelerated
tDCS for verbal memory functions. However, accelerated tDCS was found to be well-tolerated in this study.1. Introduction
A method that may improve memory functions in healthy individuals
is called transcranial direct current stimulation (tDCS) (Manenti et al.,
2013). This is a non-invasive stimulation method aimed to enhance
plasticity and learning (Prehn and Fl€oel, 2015). tDCS treatment is per-
formed by placing two or more electrodes on the scalp (one stimulation
electrode and one reference electrode). The position of the stimulation
electrode depends on the cortical area targeted for stimulation. Then, a
weak current (2 mA or less) is delivered through the stimulation elec-
trode. tDCS is simple to administer and it is associated with few adverse
effects (Brunoni et al., 2012).
tDCS works by modulation of cortical excitability and neuroplasticity
(Nitsche and Paulus, 2001). Thus, tDCS aims to increase neuroplasticity
through the process of long-term potentiation (LTP) (Monte-Silva et al.,
2013). This involves an increase in synaptic strength and is crucial for
neuroplasticity and memory (Lynch, 2004). tDCS does not directly causead).
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likely (Reinhart et al., 2017).
Previous studies suggest that tDCS may enhance memory functions
(Prehn & Fl€oel, 2015). Memory improvement from tDCS could be due to
enhanced excitability in the temporal cortex (Boggio et al., 2012; Fer-
rucci et al., 2008). Some studies also suggest that tDCS may enhance
memory consolidation by affecting resting state networks and
brain-wave frequency (e.g Annarumma et al., 2018; Kirov et al., 2009;
Marshall et al., 2011).
Sandrini and colleagues (Sandrini et al., 2014) found that a 15 min
active tDCS session could significantly improve recall of a wordlist after
30 days. Furthermore, another study found that tDCS could improve
verbal memory functions in both old and young participants (Manenti
et al., 2013). Prehn and colleagues found that a combination of selective
serotonin reuptake inhibitor (SSRI) and tDCS could give significant better
immediate memory in both younger and older participants (Prehn et al.,
2017). However, no such effects were found for delayed recall.ber 2020
article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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it could be assumed that aging can affect the efficacy of tDCS, when tDCS
is used as a memory enhancer. For instance, Ross and colleagues found
that tDCS stimulation of the temporal lobe could improve name recall for
faces in both younger and older participants (Ross et al., 2011). However,
older participants improvedmore compared to younger participants. One
assumption is that that aging weakens cortical connections and that tDCS
may enhance neuronal firing in a higher degree than for younger par-
ticipants (Gutchess, 2014). tDCS may work better for old, since younger
individuals have a nearly optimal level of neuroplasticity and thus
smaller potential for improvement. However, a recent study (Leach et al.,
2018) found that younger participants improved more than older par-
ticipants and that older participants may be less receptive to tDCS. It is
uncertain whether older participants benefit more from tDCS than
younger participants. Hence, there is a need to investigate if the effect of
tDCS differs between old and younger individuals.
It is also found that tDCS can improve memory functions in patients
with Alzheimer's disease. Boggio and colleagues (2012) found that 30
min sessions of active tDCS for five consecutive days could lead to a
nearly 10% improvement in recognitionmemory. This improvement was
prolonged for one month and was significantly higher in patients who
underwent tDCS than in those who received placebo tDCS, which only
led to a 2.6 % improvement.
On the other hand, Bystad and colleagues (2016a) found no significant
differences in memory improvement between active and placebo tDCS in
patients with Alzheimer's disease. In Alzheimer's disease, studies using
tDCS have shown inconsistent results (Kim, 2016). In healthy individuals,
tDCS is also associated with mixed results (Tremblay et al., 2014).
Before tDCS can be validated as a therapeutic tool, it is important to
investigate different stimulation protocols in healthy individuals, in
order to find the optimal stimulation protocol. In addition, since cogni-
tive functions are relevant for our function in daily life it can be useful to
investigate if tDCS leads to cognitive improvement.
The optimal number of tDCS sessions and the interval between ses-
sions remain uncertain (Woods et al., 2016). For both experimental and
clinical application of tDCS, the lack of standardized protocols possesses
a problem when conducting new studies or comparing results between
studies (Cappon et al., 2016).
It is assumed that a high repetition rate, with short intervals between
each tDCS sessions can probably be more efficient than increasing the
duration of the stimulation (Nitsche et al., 2015; Woods et al., 2016).
Such high repetition rate may lead to longer lasting effects, since the
neurophysiological after-effects of tDCS is relatively short lived. For
instance, a recent study suggested that 13 min of tDCS stimulations of
2mA leads to 90 min after-effect (Thair et al., 2017).
To prolong the effect of tDCS, it has been proposed to use short in-
tervals (<30 min) between sessions (Woods et al., 2016). Such short
intervals between each session can be referred to as “accelerated tDCS”
(Bystad, Rasmussen, Abeler and Aslaksen, 2016). A previous case study
found that such application of tDCS could improve memory functions in
patients with early stage Alzheimer's disease (Bystad et al., 2016b).
However, to date, this protocol has limited evidence.
Based on previous studies (Manenti et al., 2013; Sandrini et al., 2014),
we aimed to investigate the effect of accelerated tDCS on memory func-
tions and executive functions in both healthy old and healthy younger
participants.Weappliedanaccelerated tDCSprotocol,with short (30min)
intervals between each session. We hypothesized that active tDCS would
lead to a significantly improved verbal memory function (immediate
recall, delayed recall and recognition), compared to placebo tDCS.
2. Materials and methods
2.1. Participants
A total of 40 individuals participated in the study. There were 20 old
(59–69 years, mean age ¼ 63 years, 16 females) and 20 young (19–302
years, mean age ¼ 22 years, 13 females) participants. The eligibility
criteria were absence of any serious somatic or psychiatric conditions or
injuries to the central nervous system that could impact cognitive func-
tions. Such conditions included cancer, cerebrovascular diseases, chronic
obstructive pulmonary disease, heart failure, depression/anxiety and
psychosis. All participants completed the Hospital Anxiety and Depres-
sion Scale (HADS) (Mykletun et al., 2001), a questionnaire used to screen
for depression and anxiety.
Patients with scores above 15 on the HADS were excluded because
depression may affect cognitive functions (Lam et al., 2014).
2.2. Recruitment
Participants were recruited by advertisement. All participants were
informed that the experiment aimed to investigate if tDCS could improve
memory functions. The study was executed in a research laboratory at the
University of Tromsø, Department of Psychology. All participants signed
a written informed consent prior to participation. They were compen-
sated with a gift-card, worth 500 NOK (approximately 59 USD) after the
participation. The study was approved by the Regional Ethical Commit-
tee for Research Ethics in Medicine and Health Sciences (2012/1890).
2.3. Outcome measures
In the present study, the primary outcome measure was verbal
memory functions, assessed with the California Verbal Learning Test–-
Second Edition (CVLT-II) (Delis et al., 2004). The CVLT-II is a stan-
dardized neuropsychological test, normalized by age and gender. The
CVLT-II assess immediate recall, delayed recall and recognition. The
CVLT-II is widely used (Delis et al., 2004) and based on list-recall, where
the participant is instructed to recall a list with 16 words. The CVLT-II has
good test-retest reliability (Delis et al., 2004). To reduce test-retest
practice effects, we used the standard version at baseline, and the alter-
native form after the last tDCS session. The standard and alternative
forms have different word-lists.
The secondary outcome measures included the Trail Making Test A
and B (TMT A and TMT B) (Tombaugh, 2004) and the Digit Span test
from the Wechsler Memory Scale (WMS) (Wechsler, 1998). TMT A
measures sustained attention, speed and motor function, whereas TMT B
also assesses executive functions. It should be noted that neither the TMT
A or TMT B are memory tests. The TMT A consists of 25 circles spread
over a paper. These circles have numbers from 1-25. The participant is
instructed to draw lines to connect the circles from 1 to 25 in ascending
order and try to do this a fast as possible. The TMT B consists of circles
(1–13) and letters (A-L). The participant is instructed to draw lines as fast
as possible to connect the circles in ascending and alternating order be-
tween letters and numbers (i.e 1-A-2-B-3-C-4-D, etc.). WMS Digit Span
measures attention/working memory. The participant is instructed to
repeat a cumulative sequence of numbers forward and backward.
To control for general cognitive abilities, the Matrix Reasoning and
Vocabulary tests from the Wechsler Abbreviated Scale of Intelligence
(WASI) (Pearson, 1999) were conducted at baseline. To screen for
cognitive impairment among the old participants we used the Mini
Mental Status Evaluation (MMSE-NR) (Folstein et al., 1975).
To assess possible adverse effects, we used a questionnaire from
Brunoni and colleagues that was translated into Norwegian (Brunoni
et al., 2011). This questionnaire asks specifically about adverse effects
from the tDCS procedure, specifically regarding itching, tingling, head-
ache and discomfort (Brunoni et al., 2011).
2.4. Transcranial direct current stimulation (tDCS)
The stimulation was delivered using a direct current NeuroConn
stimulator (neuroConn, Ilmenau, Germany). This is a rechargeable
battery driven device that terminates the stimulation if the voltage
exceeds safety limits or if the impedance is too high. The impedance
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the current intensity was 2mA. The current was transferred to the
skull through a pair of 35-cm2 rubber electrodes. To improve
connection on the electrode-scalp interface we used a Ten20 neuro-
diagnostic electrode paste (Weaver and Company, Colorado, USA).
The anode (stimulation electrode) was placed at the T3 position in
the 10–20 system (a system used for electroencephalographic elec-
trode positioning). This positioning was applied in previous studies
(e.g Boggio et al., 2012) and is recommended for memory improve-
ment in Alzheimer's disease (Zhao et al., 2017). We wanted to target
the temporal lobe and found it reasonable to assume that Zhao and
collegaues (2017) recommendations should be relevant for healthy
participants. The left temporal cortex plays a major role in verbal
memory (Frisk and Milner, 1990; Johnson et al., 2001), hence, we
wanted to target this area. The cathode (reference electrode) was
placed at the Fp2 position, i.e on the right frontal lobe.
All participants were assigned their own five-digit code. This code
determined if the tDCS device should give the placebo or active stimu-
lation. Neither the experimenter nor the participant knew if the tDCS
stimulator delivered the active or placebo stimulation. Thus, the study
was double blind. The order of the codes was randomized using the
Random.org website (https://www.random.org/).
Prior to the study, we did not ask the participants about their ex-
pectations or attitude to tDCS. The electrode placement and sessions
duration were identical for active and placebo tDCS. In the beginning of
the placebo tDCS session, a current was delivered for 30 s and then there
was a “ramp-down” procedure that faded the current automatically.Figure 1.2.5. Procedure
Participants met individually for two consecutive days in a research
laboratory at the university. First, each participant received information
about the study. Then, the participant underwent the memory assess-
ment. The duration of this assessment was approximately 60 min. The
immediate and delayed recall task from CVLT-II was administrated at the
beginning of the assessment. When the assessment was completed, the
first tDCS session began. Three sessions were given on both the first day
and the second day. Each tDCS session lasted for 30 min. The break be-
tween the sessions was about 30 min. After the final tDCS session, the
participant underwent memory assessment. Here, the immediate and
delayed recall task from CVLT-II was also administrated at the beginning
of the assessment. The cognitive tests were not presented in a counter-
balanced order, since the CVLT-II has parallel versions.
See Figure 1 for an overview of the procedure.2.6. Statistical and power analysis
All data were analyzed in SPSS Version 24 We calculated the change
scores between baseline and post stimulation memory assessment scores
to investigate the effect of the tDCS stimulation. We conducted inde-
pendent t-tests to investigate the differences in the mean change of scores
between placebo and active tDCS. A Multivariate Analysis of Variance
(MANOVA) was conducted to investigate group differences between
placebo and active tDCS adjusted for age. Data were normally distrib-
uted, shown by Shapiro Wilk test.
A previous study (Sandrini et al., 2014) with healthy participants
found that active tDCS led to significant improvement in verbal memory
functions, compared to placebo tDCS. In that study, tDCS was delivered
only once, with a 15-minute duration. Based on mean scores from San-
drini et al. (2014), we used a power estimation calculator (clincalc.com)
and estimated that our study had 80 % power in order to achieve a sig-
nificant effect with a least 32 participants (16 placebo and 16 active
tDCS). Thus, we wanted to include a total of 40 participants. The
alpha-level was 0.05.3
3. Results
Table 1 displays the number of participants who improved on
different outcome scores from baseline to post-test. The analysis showed
no significant differences in CVLT-II scores between the active and the
placebo tDCS (Table 2). For CVLT-II immediate recall F ¼ 0.067, df ¼
(1.0), p ¼ 0.79, CVLT-II delayed recall F ¼ 0.24, df ¼ (1.0), p ¼ 0.62 and
CVLT-II recognition F ¼ 0.092, df ¼ (1.0), p ¼ 0.76, no significant dif-
ferences were found between the active and the placebo tDCS. However,
we found that the active group scored significantly better on change
scores than the placebo group on TMT-B, F ¼ 4.54, df ¼ (1.0), p¼ 0.040.
For the group of old participants, we found no differences in the
CVLT-II scores between active and placebo tDCS (see Table 3). For CVLT-
II immediate recall t (15.69) ¼ - 0.90, p ¼ 0.37, CVLT-II delayed recall t
(14.83) ¼ 0.18 p ¼ 0.85 and CVLT-II recognition t (11.19) ¼ 0.43, p ¼
0.67, no significant difference were found between active and placebo
tDCS. For TMT A t (17.94)¼ 2.02, p¼ 0.058 and TMT B t (15.92)¼ 0.64,
p ¼ 0.52, and Digit Span t (12.45) ¼ - 0.98, p ¼ 0.91, there was no sig-
nificant difference between active and placebo group.
For the group of younger participants, we found no difference in
CVLT-II scores between active and placebo tDCS (see Table 4). For CVLT-
II immediate recall t (18.00) ¼ 0.22, p ¼ 0.82, CVLT-II delayed recall t
(17.69)¼ - 0.82, p¼ 0.42 and CVLT-II recognition t (17.82)¼ - 0.58, p¼
0.56, and no significant difference were found between active and pla-
cebo tDCS. For TMT-A t (17.99)¼ 1.08, p¼ 0.29 and Digit Span t (16.90)
¼ - 0.48, p ¼ 0.63 there were no significant differences between the
Table 1. Frequency table.
Active tDCS (N ¼ 20) Placebo tDCS (N ¼ 20)
CVLT-II immediate recall 9 6
CVLT-II delayed recall 4 4
CVLT-II recognition 5 3
TMT-A 17 13
TMT-B 18 18
Digit Span 11 17
The data represent the number of patients who showed improvements (>) on the outcome measures.
Improvement was considered as improved scores from baseline to the post-test.
Table 2. Changes in cognitive scores for all participants (N ¼ 40).
Outcome Group Age Group Age Group * Group
F p F P F p
CVLT immediate 0.67 0.797 0.14 0.70 0.32 0.57
CVLT delayed 0.24 0.622 3.00 0.092 0.544 0.46
CVLT recogntion 0.092 0.20 0.39 0.535 0.25 0.61
TMT-A 3.02 0.91 3.81 0.59 0.007 0.93
TMT-B 4.54 0.040 0.18 0.66 0.33 0.97
Digit Span 0.84 0.365 0.77 0.78 0.055 0.81
Note: “Group” is active or placebo, “Age Group” is younger or old and “Age Group * Group” is the interaction between the group and the age group. A MANOVA analysis
was conducted.
Table 3. Change in scores for old participants (N ¼ 20).
Group Mean Std. Deviation P value Hedges g
CVLT immediate Placebo -4.90 10.98 0.37 0.38
Active -1.10 7.34
CVLT delayed Placebo -0.35 0.97 0.85 0.07
Active -0.43 1.01
CVLT recognition Placebo -0.25 0.58 0.67 0.18
Active -0.44 1.23
TMT-A Placebo -2.10 7.50 0.058 0.86
Active -9.10 7.93
TMT-B Placebo -13.80 28.05 0.52 0.28
Active -21.25 20.66
Digit Span Placebo 10.20 1.47 0.91 0.04
Active 10.10 2.51
Note: The mean values are the estimated change from baseline to post-testing (post testing minus baseline). For the CVLT-II immediate recall score, the mean value is
displayed as a T-score. For the CVLT-II delayed recall and recognition scores, the mean value are displayed as Z-scores. An independent t-test was applied to calculate the
differences between the placebo and active tDCS groups. For the CVLT scores and Digit Span scores, a positive values indicates a positive change. For TMT A and B,
negative values indicate improvements.
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0.007, the active group scored significantly better than the placebo
group.
3.1. Adverse-effects
No adverse-effects were reported, neither in young participants or old
participants, based on a questionnaire (Brunoni et al., 2011) for
adverse-effects in tDCS procedures.
4. Discussion
The aim of the present study was to investigate whether accelerated
tDCS could improve verbal memory functions in healthy young and4
healthy old participants. We also investigated whether tDCS could affect
executive functions in both young and old participants. In addition, we
wanted to study if age was a significant factor of tDCS efficacy.
We did not reveal significant differences between placebo and active
tDCS in verbal memory functions. This was not in accord with results
from two previous studies (Manenti et al., 2013; Sandrini et al., 2014).
Furthermore, we did not find any significant differences in verbal
memory between placebo and active tDCS, whilst adjusting for age.
However, we found a significant difference between placebo and
active tDCS for executive functions, as measured with TMT-B. This
significant difference was only found among the younger participants.
It should be noted that none of our participants reported any adverse
effects, despite the short intervals between each the tDCS sessions.
Accelerated tDCS seems to be both safe and well-tolerated in our
Table 4. Changes in scores for younger participants (N ¼ 20).
Outcome Group Mean Std. Deviation P value Hedges g
CVLT immediate Placebo -4.30 9.80 0.82 0.09
Active -5.30 9.83
CVLT delayed Placebo -1.25 1.29 0.42 0.35
Active -0.80 1.13
CVLT recognition Placebo -0.60 0.90 0.56 0.26
Active -0.35 1.00
TMT-A Placebo -8.00 9.92 0.29 0.46
Active -12.80 9.79
TMT-B Placebo -10.20 6.90 0.007* 1.39
Active -30.50 18.43
Digit Span Placebo 0.50 2.06 0.63 0.20
Active 0.90 1.59
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participants.
The reason for our non-significant effect of tDCS on verbal memory
functions may be attributed to several different causes. First, we applied a
novel stimulation protocol (i.e., accelerated tDCS, with short intervals
between each session). To our knowledge, no studies have investigated
such an intensive protocol. Accelerated tDCS is based on recommenda-
tions from Nitsche and colleagues (2015), rather than evidence. This
protocol may not be as efficient as we expected.
Second, it also uncertain if tDCS actually leads to cognitive (Horvath,
Forte and Carter, 2015b) and neurophysiological (Horvath, Forte and
Carter, 2015a) changes in healthy individuals. Horvath and colleagues
argue that tDCS has some major shortcomings (e.g., electric current in-
fluences, inter-subject variability) (Horvath et al., 2014). For instance,
Tremblay (2014) reported that one participant experienced a 251 % in-
crease in motor evoked potentials, whereas another participant experi-
enced a 41 % decrease. Anatomic differences (e.g skull thickness) and
neurophysiology are individual factors that may affect the distribution of
current flow to the cortex (Horvath et al., 2014). The effect of tDCS on
cognitive function in healthy participants is associated with conflicting
results (Tremblay et al., 2014). Such intra-individual sensitivity to tDCS
may be an obstacle in pursuing its effect on cognition. Thus, it is un-
certain whether the between subject design is the most appropriate
choice for investigation of effects of tDCS on cognitive function.
Hsu and colleagues (2015) argues that tDCS may work best in path-
ological states and benefit those who need it most, since there may be a
ceiling effect in healthy participants and tDCS may serve to strength
weaken pathological neural circuits. Consequently, we cannot disregard
a lack of effect from our tDCS stimulation.
We revealed a significant effect on executive functions in the young
participants. A possible explanation is the limitation of the TMT-B test,
which was used to measure executive functions. TMT-B seems to have
substantial test-retest practice effects, especially over a short interval
(Bartels et al., 2010). For instance, a study (Bartels et al., 2010) found
that retest with TMT-B after three weeks could improve the score with
nearly 10 s. Since memory test usually have parallel versions, TMT-A and
TMT-B are more susceptible to test-retest practice effects. According to
our results (Table 1), most participants improved on the TMT-B test,
regardless of placebo or active tDCS. We cannot completely rule out a
test-retest practice effect.
Further, tDCS has low specificity (Csifcsak et al., 2018). Even if our
aim was to stimulate temporal cortex, other cortical areas may also have
been affected (e.g frontal cortex), since tDCS may lead to a widespread
alterations of functional connectivity (Keeser et al., 2011). It is suggested
that tDCS may enhance alerting attention (Coffman et al., 2012) and
affecting the resting state networks (e.g Annarumma et al., 2018; Kirov
et al., 2009) This could improve executive function, and thus lead to
better scores on TMT-B. Effects of tDCS on resting state connectivity may5
be different in younger adults (Prehn and Fl€oel, 2015; Woods et al.,
2019).4.1. Limitation
The present study has several limitations that needs to be addressed.
One limitation is that we relied solely on cognitive functions for our
outcome measures. Consequently, we do not know if the tDCS stimula-
tion induced any neurophysiological changes. There may be a chance
that our tDCS protocol affected neuroplasticity and neural activity.
However, this remains unknown in our study.
Further, a second limitation is our “one size fits all” approach. It is
reasonable to assume that anatomical differences (e.g., skull thickness)
can affect the efficacy of the tDCS stimulation, i.e how the current is
distributed to the cortex. We did not apply a computational model to
calibrate the tDCS stimulation for each participant. Our lack of individual
calibration is a limitation, since individual differences can be an impor-
tant factor (Sarkar et al., 2014).
A third limitation is that we did not combine tDCS with any cognitive
stimulation. We only applied tDCS. This could affect the efficacy of our
tDCS protocol, since the effect of tDCS may improve when tDCS and
cognitive stimulation are used simultaneously (Hsu et al., 2015).4.2. Future research
Further research should take advantage of both memory/cognitive
assessment and psychophysiological measures (e.g., event-related po-
tentials or neuroimaging). A combination of such outcome measures will
provide insight into the cognitive and neurophysiological effect of tDCS.
There is clearly a need to investigate the potential effect of tDCS on
neurobiological changes in healthy individuals. For future research, it
can also be useful to calibrate the tDCS procedure for each participant. A
computation model can be applied in order to determine out how indi-
vidual differences will affect the current distribution. In addition, it could
be of potential interest to study the effect when tDCS and cognitive
stimulation are delivered simultaneously.4.3. Conclusions
This experimental study did not reveal a significant difference be-
tween active and placebo accelerated tDCS for verbal memory functions.
However, we found that the tDCS stimulation led to a significant
improvement in executive function in younger participants, assessed
with TMT-B. Our accelerated tDCS protocol, with short intervals between
each session, was well tolerated with no side effects of the stimulation.
Future research should combine memory/cognitive and neurophysio-
logical outcome measures.
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